Robert Remler
Internal Medicine · Savannah, GANPI 1316946114
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 245 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,598 and has fallen 89.3% since, to $171 in 2021.
Across 245 payments — averaging $10.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$562
- Supernus Pharmaceuticals, Inc.$362
- AstraZeneca$294
- Novo Nordisk$207
- Pfizer$147
- Novartis$142
- plus $812 from 20 others
Across 10 payments — averaging $25,389 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$253K
- Eli Lilly$1K
What the payments were for
- Food & beverage$2,526100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 18 | $562 |
| Supernus Pharmaceuticals, Inc. | 125 | $362 |
| AstraZeneca(2 entities) | 20 | $294 |
| Novo Nordisk | 9 | $207 |
| Pfizer | 11 | $147 |
| Novartis | 9 | $142 |
| Sanofi-aventis U.S. LLC | 9 | $142 |
| AbbVie(2 entities) | 8 | $120 |
| Esperion Therapeutics, Inc. | 4 | $67 |
| Boehringer Ingelheim | 4 | $57 |
| Amarin Pharma, Inc. | 3 | $56 |
| Merck | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $34 |
| Astellas Pharma US Inc | 2 | $33 |
| GSK | 2 | $30 |
| Boston Scientific | 2 | $29 |
| Eisai Inc. | 2 | $29 |
| Johnson & Johnson | 2 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Lilly USA, LLC | 2 | $24 |
| Pacira Therapeutics, Inc. | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Biogen | 1 | $15 |
| Radius Health, Inc. | 1 | $15 |
| Mannkind Corporation | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,526 in reported general payments places this provider in the 80th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Savannah
- Jennifer WoehlerSavannah$207K
- Timothy ConnellySavannah$50K
- John DemiccoSavannah$31K
- Paul BradleySavannah$28K
- Wilfredo DolorSavannah$17K
- Thomas HoganSavannah$17K
- Thomas MoriaritySavannah$16K
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.